Blog

“Among individuals who have suffered traumatic limb loss, recovery starts with pre-prosthetic training, education with a talented prosthetist, and prosthetic training. Cray Frounfelter, prosthetist and amputee, explains the path,” states Greg Vigna, MD, JD, Vigna Law Group. Greg Vigna, MD, JD, national pharmaceutical injury attorney, states “I learned early on, as a Board-Certified Physical Medicine […]

“Some ACOG members may be less familiar with research indicating that pudendal neuralgia can be associated with soft tissue impacts from mid-urethral slings marketed in the United States,” states Greg Vigna, MD, JD, national pudendal neuralgia lawyer. Dr. Greg Vigna, MD, JD, Board Certified in Physical Medicine and Rehabilitation, states, “There is ongoing discussion within […]

“Coloplast and Boston Scientific have failed to introduce PVDF to the market, even as it gains market share in Europe and other regions. I remain engaged in addressing medical malpractice and product-related claims nationwide while advocating for consideration of materials like PVDF that may offer a more favorable safety profile,” states Greg Vigna, MD, JD, […]

Greg Vigna, MD, JD, a national pharmaceutical injury attorney, states, “Amgen is not removing its drug despite the FDA’s request. Reported complications include acute liver injury and death.” Dr. Greg Vigna, MD, JD, a national medical malpractice and product liability attorney, states, “The FDA re-adjudicated the data used to support the FDA’s approval of Tavneos […]

“Andexxa was an antidote for major bleeding complications caused by Xarelto and Eliquis, including intracerebral and intra-abdominal. While Andexxa stopped the bleeding, it was associated with a 2.1-fold increase in blood clots and a 2.8-fold increase in deaths compared with usual care,” states Greg Vigna, MD, JD, national pharmaceutical injury attorney. Click here to read the […]

 “At some point, physicians can be held liable for prescribing Depo-Provera when there are alternative birth control medications that do not cause mutations that lead to brain tumors. The literature on this is clear,” states Greg Vigna, MD, JD, national malpractice, Depo-Provera attorney. Dr. Greg Vigna, MD, JD, says, “We filed this case because drug […]

“Pfizer, to this day, does not disclose in its warnings that Depo-Provera is mutagenic, despite clear evidence of a dose-dependent increased risk of meningiomas in women injected with the drug for one year or more, and evidence of a specific mutational tendency associated with its use,” states Greg Vigna, MD, JD, national neurological injury attorney. […]

“Progesterone-only contraception is associated with a shorter progression-free survival in premenopausal women with WHO Grade I meningioma,” states D. Ryan Ormond, MD, Ph.D, Neurosurgery, University of Colorado. What does Dr. Ormond say about the continued use of Depo-Provera after meningioma resection, published in the Journal of Neuro-oncology in 2018? “Compared to patients taking combination or […]